Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7134)
All Articles published online
|
Publishing Process of This Article
|
Aug 6, 2014 (publication date) through Nov 15, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hematology
ISSN
2218-6204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ohnishi H, Imataki O, Kawachi Y, Ide M, Kawakami K, Waki M, Takimoto H, Hoshijima Y, Fukumoto T, Matsumoto K, Waki F, Matsuoka A, Shintani T, Uemura M, Yokokura S, Taoka T, Matsunaga T. Age is an independent adverse prognostic factor for overall survival in acute myeloid leukemia in Japan. World J Hematol 2014; 3(3): 105-114 [DOI: 10.5315/wjh.v3.i3.105] |
|---|---|
| URL: | https://www.wjgnet.com/2218-6204/full/v3/i3/105.htm |
| Number | Citing Articles |
| 1 |
Takahiro Yamauchi, Chikashi Yoshida, Kensuke Usuki, Satoru Takada, Itaru Matsumura, Nobuaki Dobashi, Yasushi Miyazaki, Toshihiro Miyamoto, Hiroatsu Iida, Norio Asou, Junya Kuroda, Satoshi Ichikawa, Norio Komatsu, Wellington Mendes, Hideyuki Honda, Sumiko Okubo, Misaki Kurokawa, Qi Jiang, Andrew Wei, Kenichi Ishizawa. Venetoclax plus low-dose cytarabine in Japanese patients with untreated acute myeloid leukaemia ineligible for intensive chemotherapy. Japanese Journal of Clinical Oncology 2021; 51(9): 1372 doi: 10.1093/jjco/hyab112
|
| 2 |
Gunnar Juliusson, Sören Lehmann, Vladimir Lazarevic. Acute Myeloid Leukemia. Hematologic Malignancies 2021; : 1 doi: 10.1007/978-3-030-72676-8_1
|